BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard J Nowak, MD, MS
Yale University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of California - Davis
Davis, California, United States
- University of California - Los Angeles
Los Angeles, California, United States
- University of Colorado - Denver
Denver, Colorado, United States
- Yale School of Medicine, Department of Neurology
New Haven, Connecticut, United States
- University of Miami School of Medicine
Miami, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern University
Evanston, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Brigham & Women'S Hospital
Boston, Massachusetts, United States
- Washington University
St Louis, Missouri, United States
- Suny Downstate Medical Center
Brooklyn, New York, United States
- Suny Buffalo
Buffalo, New York, United States
- Columbia University Medical Center
New York, New York, United States
- Weill Cornell Medical Center
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- Suny Stony Brook
Stony Brook, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- University of Cincinnati
Cincinnati, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- University of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
- Swedish Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2014
- Primary completion
- 31 Jul 2017
- Completion
- 31 May 2018
- Last update posted
- 6 Mar 2020
- Registered enrollment
- 52
- Registry id
- NCT02110706
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.